Translational funding opportunities from GHIT Fund
Application deadline
EOI deadline: 10 July (stage 2 - by invitation only closing 7 August)
Award volume and duration
Volume varies; up to 2 years
About the call
The GHIT Fund invests in the research and development of new health technologies, including drugs, vaccines and diagnostics, for infectious diseases prevalent in low-income countries (LICs) and lower-middle-income countries (LMICs). The Product Development Platform offers support for innovative global health research and development including: 1) lead optimization, 2) preclinical development, 3) clinical development, 4) parallel or concurrent development of multiple interventions, and 5) activities to support licensure and WHO prequalification.
How to apply
Application deadline
EOI deadline: 10 July (stage 2 by invite only - closing 7 August)
Award volume and duration
up to £465k, up to 2 years
About the call
The GHIT Fund invests in the research and development of new health technologies, including drugs, vaccines and diagnostics, for infectious diseases prevalent in low-income countries (LICs) and lower-middle-income countries (LMICs). The Target Research Platform (TRP) is intended to support the crucial, earlier phase of R&D discovery of new approaches, concepts, constructs and solutions to fight neglected infectious diseases. Three types of awards are available under the Target Research Platform namely Standard TRP Award, Strategic Innovation and Market Assessment Award, and Pandemic Preparedness and Response Award.